Following promising clinical findings , retatrutide, a novel peptide therapy for managing type 2 hyperglycemia , has received conditional approval from UK’s Healthcare and Regulatory Agency ( MHRA https://shopretatrutidepeptide.com/category/retatrutide-peptide/